nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—PPARG—polycystic ovary syndrome	0.731	1	CbGaD
Telmisartan—CYP2C19—urine—polycystic ovary syndrome	0.00567	0.105	CbGeAlD
Telmisartan—Toothache—Metformin—polycystic ovary syndrome	0.00402	0.0445	CcSEcCtD
Telmisartan—Upset stomach—Metformin—polycystic ovary syndrome	0.00374	0.0413	CcSEcCtD
Telmisartan—SLCO1B3—pituitary gland—polycystic ovary syndrome	0.00322	0.0598	CbGeAlD
Telmisartan—Fungal infection—Metformin—polycystic ovary syndrome	0.00317	0.0351	CcSEcCtD
Telmisartan—Rigors—Metformin—polycystic ovary syndrome	0.003	0.0332	CcSEcCtD
Telmisartan—SLCO1B3—vagina—polycystic ovary syndrome	0.00267	0.0495	CbGeAlD
Telmisartan—SLCO1B3—endocrine gland—polycystic ovary syndrome	0.00249	0.0463	CbGeAlD
Telmisartan—PPARG—embryo—polycystic ovary syndrome	0.00243	0.045	CbGeAlD
Telmisartan—AGTR1—adrenal cortex—polycystic ovary syndrome	0.00242	0.0449	CbGeAlD
Telmisartan—Ear pain—Metformin—polycystic ovary syndrome	0.00208	0.023	CcSEcCtD
Telmisartan—AGTR1—pituitary gland—polycystic ovary syndrome	0.00195	0.0363	CbGeAlD
Telmisartan—AGTR1—adipose tissue—polycystic ovary syndrome	0.00194	0.0361	CbGeAlD
Telmisartan—Renal impairment—Metformin—polycystic ovary syndrome	0.00187	0.0207	CcSEcCtD
Telmisartan—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00182	0.0201	CcSEcCtD
Telmisartan—Pain in extremity—Metformin—polycystic ovary syndrome	0.00178	0.0197	CcSEcCtD
Telmisartan—Migraine—Metformin—polycystic ovary syndrome	0.00175	0.0193	CcSEcCtD
Telmisartan—AGTR1—adrenal gland—polycystic ovary syndrome	0.00174	0.0324	CbGeAlD
Telmisartan—PPARG—uterus—polycystic ovary syndrome	0.00164	0.0304	CbGeAlD
Telmisartan—AGTR1—vagina—polycystic ovary syndrome	0.00162	0.03	CbGeAlD
Telmisartan—Breast disorder—Metformin—polycystic ovary syndrome	0.00161	0.0178	CcSEcCtD
Telmisartan—Cramp muscle—Metformin—polycystic ovary syndrome	0.0016	0.0177	CcSEcCtD
Telmisartan—PPARG—adipose tissue—polycystic ovary syndrome	0.0016	0.0297	CbGeAlD
Telmisartan—Abdominal distension—Metformin—polycystic ovary syndrome	0.00155	0.0171	CcSEcCtD
Telmisartan—AGTR1—endocrine gland—polycystic ovary syndrome	0.00151	0.0281	CbGeAlD
Telmisartan—Sweating increased—Metformin—polycystic ovary syndrome	0.0015	0.0165	CcSEcCtD
Telmisartan—Angina pectoris—Metformin—polycystic ovary syndrome	0.0015	0.0165	CcSEcCtD
Telmisartan—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00147	0.0163	CcSEcCtD
Telmisartan—PPARG—adrenal gland—polycystic ovary syndrome	0.00143	0.0266	CbGeAlD
Telmisartan—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00143	0.0158	CcSEcCtD
Telmisartan—Infestation NOS—Metformin—polycystic ovary syndrome	0.00137	0.0151	CcSEcCtD
Telmisartan—Infestation—Metformin—polycystic ovary syndrome	0.00137	0.0151	CcSEcCtD
Telmisartan—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00134	0.0148	CcSEcCtD
Telmisartan—PPARG—female gonad—polycystic ovary syndrome	0.00134	0.0248	CbGeAlD
Telmisartan—PPARG—vagina—polycystic ovary syndrome	0.00133	0.0247	CbGeAlD
Telmisartan—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.0013	0.0143	CcSEcCtD
Telmisartan—ABCG2—adrenal cortex—polycystic ovary syndrome	0.00127	0.0237	CbGeAlD
Telmisartan—ABCC2—adrenal gland—polycystic ovary syndrome	0.00126	0.0234	CbGeAlD
Telmisartan—Bradycardia—Metformin—polycystic ovary syndrome	0.00125	0.0138	CcSEcCtD
Telmisartan—PPARG—endocrine gland—polycystic ovary syndrome	0.00124	0.0231	CbGeAlD
Telmisartan—Rhinitis—Metformin—polycystic ovary syndrome	0.00123	0.0136	CcSEcCtD
Telmisartan—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00122	0.0135	CcSEcCtD
Telmisartan—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00121	0.0134	CcSEcCtD
Telmisartan—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00121	0.0134	CcSEcCtD
Telmisartan—Eye disorder—Metformin—polycystic ovary syndrome	0.00115	0.0127	CcSEcCtD
Telmisartan—Flushing—Metformin—polycystic ovary syndrome	0.00114	0.0126	CcSEcCtD
Telmisartan—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00114	0.0126	CcSEcCtD
Telmisartan—ABCG2—endometrium—polycystic ovary syndrome	0.00114	0.0211	CbGeAlD
Telmisartan—Angiopathy—Metformin—polycystic ovary syndrome	0.00112	0.0123	CcSEcCtD
Telmisartan—Immune system disorder—Metformin—polycystic ovary syndrome	0.00111	0.0123	CcSEcCtD
Telmisartan—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00111	0.0123	CcSEcCtD
Telmisartan—Chills—Metformin—polycystic ovary syndrome	0.0011	0.0122	CcSEcCtD
Telmisartan—ABCC2—endocrine gland—polycystic ovary syndrome	0.00109	0.0203	CbGeAlD
Telmisartan—Malnutrition—Metformin—polycystic ovary syndrome	0.00107	0.0118	CcSEcCtD
Telmisartan—Erythema—Metformin—polycystic ovary syndrome	0.00107	0.0118	CcSEcCtD
Telmisartan—Flatulence—Metformin—polycystic ovary syndrome	0.00105	0.0117	CcSEcCtD
Telmisartan—ABCG2—uterus—polycystic ovary syndrome	0.00105	0.0195	CbGeAlD
Telmisartan—Dysgeusia—Metformin—polycystic ovary syndrome	0.00105	0.0116	CcSEcCtD
Telmisartan—ABCG2—pituitary gland—polycystic ovary syndrome	0.00103	0.0191	CbGeAlD
Telmisartan—Muscle spasms—Metformin—polycystic ovary syndrome	0.00103	0.0114	CcSEcCtD
Telmisartan—ABCG2—adipose tissue—polycystic ovary syndrome	0.00103	0.019	CbGeAlD
Telmisartan—CYP2C19—vagina—polycystic ovary syndrome	0.001	0.0186	CbGeAlD
Telmisartan—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000993	0.011	CcSEcCtD
Telmisartan—Malaise—Metformin—polycystic ovary syndrome	0.000965	0.0107	CcSEcCtD
Telmisartan—Syncope—Metformin—polycystic ovary syndrome	0.00096	0.0106	CcSEcCtD
Telmisartan—Palpitations—Metformin—polycystic ovary syndrome	0.000946	0.0105	CcSEcCtD
Telmisartan—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000941	0.0104	CcSEcCtD
Telmisartan—CYP2C19—endocrine gland—polycystic ovary syndrome	0.00094	0.0174	CbGeAlD
Telmisartan—Hypertension—Metformin—polycystic ovary syndrome	0.000924	0.0102	CcSEcCtD
Telmisartan—ABCG2—adrenal gland—polycystic ovary syndrome	0.00092	0.0171	CbGeAlD
Telmisartan—Chest pain—Metformin—polycystic ovary syndrome	0.000911	0.0101	CcSEcCtD
Telmisartan—Myalgia—Metformin—polycystic ovary syndrome	0.000911	0.0101	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000905	0.01	CcSEcCtD
Telmisartan—Discomfort—Metformin—polycystic ovary syndrome	0.0009	0.00996	CcSEcCtD
Telmisartan—Oedema—Metformin—polycystic ovary syndrome	0.000874	0.00966	CcSEcCtD
Telmisartan—Infection—Metformin—polycystic ovary syndrome	0.000868	0.0096	CcSEcCtD
Telmisartan—Shock—Metformin—polycystic ovary syndrome	0.000859	0.00951	CcSEcCtD
Telmisartan—ABCG2—female gonad—polycystic ovary syndrome	0.000857	0.0159	CbGeAlD
Telmisartan—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000857	0.00947	CcSEcCtD
Telmisartan—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000855	0.00946	CcSEcCtD
Telmisartan—ABCG2—vagina—polycystic ovary syndrome	0.000852	0.0158	CbGeAlD
Telmisartan—Skin disorder—Metformin—polycystic ovary syndrome	0.000849	0.00938	CcSEcCtD
Telmisartan—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000845	0.00934	CcSEcCtD
Telmisartan—Anorexia—Metformin—polycystic ovary syndrome	0.000833	0.00921	CcSEcCtD
Telmisartan—Hypotension—Metformin—polycystic ovary syndrome	0.000816	0.00903	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000796	0.0088	CcSEcCtD
Telmisartan—Paraesthesia—Metformin—polycystic ovary syndrome	0.000784	0.00868	CcSEcCtD
Telmisartan—Dyspnoea—Metformin—polycystic ovary syndrome	0.000779	0.00861	CcSEcCtD
Telmisartan—Somnolence—Metformin—polycystic ovary syndrome	0.000777	0.00859	CcSEcCtD
Telmisartan—Dyspepsia—Metformin—polycystic ovary syndrome	0.000769	0.0085	CcSEcCtD
Telmisartan—ABCB1—embryo—polycystic ovary syndrome	0.000767	0.0142	CbGeAlD
Telmisartan—Decreased appetite—Metformin—polycystic ovary syndrome	0.000759	0.0084	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000754	0.00834	CcSEcCtD
Telmisartan—Fatigue—Metformin—polycystic ovary syndrome	0.000753	0.00833	CcSEcCtD
Telmisartan—Constipation—Metformin—polycystic ovary syndrome	0.000747	0.00826	CcSEcCtD
Telmisartan—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00072	0.00796	CcSEcCtD
Telmisartan—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000714	0.0079	CcSEcCtD
Telmisartan—Urticaria—Metformin—polycystic ovary syndrome	0.000694	0.00768	CcSEcCtD
Telmisartan—Abdominal pain—Metformin—polycystic ovary syndrome	0.000691	0.00764	CcSEcCtD
Telmisartan—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000628	0.0117	CbGeAlD
Telmisartan—Asthenia—Metformin—polycystic ovary syndrome	0.000627	0.00693	CcSEcCtD
Telmisartan—Pruritus—Metformin—polycystic ovary syndrome	0.000618	0.00684	CcSEcCtD
Telmisartan—Diarrhoea—Metformin—polycystic ovary syndrome	0.000598	0.00661	CcSEcCtD
Telmisartan—Dizziness—Metformin—polycystic ovary syndrome	0.000578	0.00639	CcSEcCtD
Telmisartan—ABCB1—endometrium—polycystic ovary syndrome	0.000561	0.0104	CbGeAlD
Telmisartan—Vomiting—Metformin—polycystic ovary syndrome	0.000555	0.00614	CcSEcCtD
Telmisartan—Rash—Metformin—polycystic ovary syndrome	0.000551	0.00609	CcSEcCtD
Telmisartan—Dermatitis—Metformin—polycystic ovary syndrome	0.00055	0.00609	CcSEcCtD
Telmisartan—Headache—Metformin—polycystic ovary syndrome	0.000547	0.00605	CcSEcCtD
Telmisartan—Nausea—Metformin—polycystic ovary syndrome	0.000519	0.00574	CcSEcCtD
Telmisartan—ABCB1—uterus—polycystic ovary syndrome	0.000517	0.0096	CbGeAlD
Telmisartan—ABCB1—pituitary gland—polycystic ovary syndrome	0.000508	0.00943	CbGeAlD
Telmisartan—ABCB1—adipose tissue—polycystic ovary syndrome	0.000506	0.00939	CbGeAlD
Telmisartan—ABCB1—adrenal gland—polycystic ovary syndrome	0.000453	0.00842	CbGeAlD
Telmisartan—ABCB1—female gonad—polycystic ovary syndrome	0.000423	0.00785	CbGeAlD
Telmisartan—ABCB1—vagina—polycystic ovary syndrome	0.00042	0.0078	CbGeAlD
Telmisartan—ABCB1—endocrine gland—polycystic ovary syndrome	0.000393	0.0073	CbGeAlD
Telmisartan—CYP2C19—Biological oxidations—CYP19A1—polycystic ovary syndrome	7.87e-05	0.000633	CbGpPWpGaD
Telmisartan—CYP2C19—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	7.76e-05	0.000624	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	7.59e-05	0.00061	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—FSHR—polycystic ovary syndrome	7.58e-05	0.000609	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—STAR—polycystic ovary syndrome	7.57e-05	0.000609	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	7.57e-05	0.000609	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—HSD3B1—polycystic ovary syndrome	7.55e-05	0.000607	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	7.49e-05	0.000602	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	7.46e-05	0.0006	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	7.46e-05	0.0006	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	7.45e-05	0.000598	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—POMC—polycystic ovary syndrome	7.42e-05	0.000597	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—GHRL—polycystic ovary syndrome	7.37e-05	0.000592	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—TEAD2—polycystic ovary syndrome	7.29e-05	0.000586	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—AKR1C2—polycystic ovary syndrome	7.29e-05	0.000586	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	7.2e-05	0.000579	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	7.13e-05	0.000573	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—NCOR1—polycystic ovary syndrome	7.13e-05	0.000573	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	7.07e-05	0.000568	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	7.01e-05	0.000563	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	6.94e-05	0.000558	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	6.93e-05	0.000557	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—LHB—polycystic ovary syndrome	6.88e-05	0.000553	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	6.87e-05	0.000553	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	6.87e-05	0.000552	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—FST—polycystic ovary syndrome	6.76e-05	0.000543	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—HMMR—polycystic ovary syndrome	6.75e-05	0.000543	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—HSD3B2—polycystic ovary syndrome	6.73e-05	0.000541	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	6.72e-05	0.00054	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ADRB3—polycystic ovary syndrome	6.67e-05	0.000536	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—LHB—polycystic ovary syndrome	6.59e-05	0.00053	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—AKR1C1—polycystic ovary syndrome	6.51e-05	0.000524	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	6.49e-05	0.000522	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—GNRH1—polycystic ovary syndrome	6.45e-05	0.000518	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—HSD3B1—polycystic ovary syndrome	6.44e-05	0.000518	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—IL6—polycystic ovary syndrome	6.37e-05	0.000512	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	6.36e-05	0.000512	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	6.35e-05	0.00051	CbGpPWpGaD
Telmisartan—CYP2C19—Biological oxidations—CYP1A1—polycystic ovary syndrome	6.35e-05	0.00051	CbGpPWpGaD
Telmisartan—CYP2C19—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	6.26e-05	0.000503	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—polycystic ovary syndrome	6.24e-05	0.000502	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	6.24e-05	0.000502	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	6.23e-05	0.000501	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SCT—polycystic ovary syndrome	6.18e-05	0.000497	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—YAP1—polycystic ovary syndrome	6.14e-05	0.000494	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PNPLA2—polycystic ovary syndrome	6.11e-05	0.000491	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	6.1e-05	0.00049	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	6.03e-05	0.000485	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	6.03e-05	0.000485	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—SULT2A1—polycystic ovary syndrome	6e-05	0.000482	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	5.9e-05	0.000474	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—LHB—polycystic ovary syndrome	5.87e-05	0.000472	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—LEP—polycystic ovary syndrome	5.86e-05	0.000471	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	5.86e-05	0.000471	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	5.84e-05	0.000469	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—RRM2—polycystic ovary syndrome	5.81e-05	0.000467	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—FGF18—polycystic ovary syndrome	5.79e-05	0.000466	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—SRD5A1—polycystic ovary syndrome	5.79e-05	0.000465	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—RBP4—polycystic ovary syndrome	5.74e-05	0.000462	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—HSD3B2—polycystic ovary syndrome	5.74e-05	0.000461	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	5.72e-05	0.00046	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—GNAS—polycystic ovary syndrome	5.66e-05	0.000455	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—YAP1—polycystic ovary syndrome	5.6e-05	0.00045	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NMNAT3—polycystic ovary syndrome	5.58e-05	0.000449	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—AKR1C1—polycystic ovary syndrome	5.56e-05	0.000447	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—STAR—polycystic ovary syndrome	5.52e-05	0.000444	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	5.52e-05	0.000444	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NMNAT3—polycystic ovary syndrome	5.45e-05	0.000438	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—TNRC6B—polycystic ovary syndrome	5.42e-05	0.000435	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—VEGFA—polycystic ovary syndrome	5.41e-05	0.000435	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—NAMPT—polycystic ovary syndrome	5.38e-05	0.000432	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—YAP1—polycystic ovary syndrome	5.36e-05	0.000431	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—PGR—polycystic ovary syndrome	5.36e-05	0.000431	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	5.35e-05	0.00043	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	5.33e-05	0.000428	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	5.32e-05	0.000428	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CYP11A1—polycystic ovary syndrome	5.31e-05	0.000427	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—GAB1—polycystic ovary syndrome	5.29e-05	0.000425	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	5.27e-05	0.000424	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	5.2e-05	0.000418	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—SULT2A1—polycystic ovary syndrome	5.12e-05	0.000411	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—LPCAT2—polycystic ovary syndrome	5.11e-05	0.00041	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SUOX—polycystic ovary syndrome	5.11e-05	0.00041	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—INSR—polycystic ovary syndrome	5.06e-05	0.000407	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	5.04e-05	0.000405	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—AKR1C3—polycystic ovary syndrome	5.01e-05	0.000403	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—INS—polycystic ovary syndrome	5.01e-05	0.000403	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—LPCAT2—polycystic ovary syndrome	4.98e-05	0.000401	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SUOX—polycystic ovary syndrome	4.98e-05	0.000401	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—RRM2—polycystic ovary syndrome	4.95e-05	0.000398	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CYP17A1—polycystic ovary syndrome	4.94e-05	0.000397	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—HMMR—polycystic ovary syndrome	4.92e-05	0.000396	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	4.89e-05	0.000393	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—AKT2—polycystic ovary syndrome	4.84e-05	0.000389	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	4.81e-05	0.000386	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—YAP1—polycystic ovary syndrome	4.78e-05	0.000384	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ISYNA1—polycystic ovary syndrome	4.75e-05	0.000382	CbGpPWpGaD
Telmisartan—CYP2C19—Biological oxidations—POMC—polycystic ovary syndrome	4.73e-05	0.00038	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	4.73e-05	0.00038	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—HSD3B1—polycystic ovary syndrome	4.69e-05	0.000377	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PGR—polycystic ovary syndrome	4.68e-05	0.000376	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	4.64e-05	0.000373	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ISYNA1—polycystic ovary syndrome	4.63e-05	0.000372	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	4.63e-05	0.000372	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—NAMPT—polycystic ovary syndrome	4.59e-05	0.000369	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CYP11A1—polycystic ovary syndrome	4.53e-05	0.000364	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	4.5e-05	0.000362	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—IL6—polycystic ovary syndrome	4.49e-05	0.000361	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PLAT—polycystic ovary syndrome	4.35e-05	0.00035	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—GHRL—polycystic ovary syndrome	4.35e-05	0.00035	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	4.33e-05	0.000348	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—LHB—polycystic ovary syndrome	4.28e-05	0.000344	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—AKR1C3—polycystic ovary syndrome	4.28e-05	0.000344	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—TH—polycystic ovary syndrome	4.27e-05	0.000343	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CYP17A1—polycystic ovary syndrome	4.21e-05	0.000339	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—POMC—polycystic ovary syndrome	4.19e-05	0.000337	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—HSD3B2—polycystic ovary syndrome	4.18e-05	0.000336	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—AR—polycystic ovary syndrome	4.17e-05	0.000335	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—SLC2A4—polycystic ovary syndrome	4.16e-05	0.000334	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ATF1—polycystic ovary syndrome	4.15e-05	0.000334	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	4.11e-05	0.00033	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	4.08e-05	0.000328	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—AKR1C1—polycystic ovary syndrome	4.05e-05	0.000326	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	4.05e-05	0.000326	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—AKR1C2—polycystic ovary syndrome	4.04e-05	0.000324	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—TEAD2—polycystic ovary syndrome	4.04e-05	0.000324	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	4.03e-05	0.000324	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	3.94e-05	0.000317	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	3.94e-05	0.000317	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CYP19A1—polycystic ovary syndrome	3.91e-05	0.000314	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	3.88e-05	0.000312	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NGFR—polycystic ovary syndrome	3.83e-05	0.000308	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	3.82e-05	0.000307	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—POMC—polycystic ovary syndrome	3.81e-05	0.000306	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PRL—polycystic ovary syndrome	3.8e-05	0.000305	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—SULT2A1—polycystic ovary syndrome	3.73e-05	0.0003	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—AKT2—polycystic ovary syndrome	3.66e-05	0.000294	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—NCOR1—polycystic ovary syndrome	3.65e-05	0.000293	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—TH—polycystic ovary syndrome	3.64e-05	0.000293	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—RRM2—polycystic ovary syndrome	3.61e-05	0.00029	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ADRB2—polycystic ovary syndrome	3.6e-05	0.00029	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	3.57e-05	0.000287	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—SLC2A4—polycystic ovary syndrome	3.55e-05	0.000285	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	3.51e-05	0.000282	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GNAS—polycystic ovary syndrome	3.49e-05	0.00028	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—YAP1—polycystic ovary syndrome	3.48e-05	0.00028	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PNPLA2—polycystic ovary syndrome	3.38e-05	0.000272	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—NR3C1—polycystic ovary syndrome	3.37e-05	0.000271	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—NAMPT—polycystic ovary syndrome	3.35e-05	0.000269	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—GNAS—polycystic ovary syndrome	3.34e-05	0.000269	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CYP19A1—polycystic ovary syndrome	3.33e-05	0.000268	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—NCOR1—polycystic ovary syndrome	3.32e-05	0.000267	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP11A1—polycystic ovary syndrome	3.3e-05	0.000266	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	3.3e-05	0.000265	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	3.26e-05	0.000262	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SRD5A1—polycystic ovary syndrome	3.21e-05	0.000258	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NCOR1—polycystic ovary syndrome	3.18e-05	0.000256	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—VEGFA—polycystic ovary syndrome	3.16e-05	0.000254	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CYP1A1—polycystic ovary syndrome	3.15e-05	0.000253	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	3.13e-05	0.000252	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NRG1—polycystic ovary syndrome	3.12e-05	0.000251	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—AKR1C3—polycystic ovary syndrome	3.12e-05	0.000251	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP17A1—polycystic ovary syndrome	3.07e-05	0.000247	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—STAR—polycystic ovary syndrome	3.06e-05	0.000246	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	3.02e-05	0.000243	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—STAR—polycystic ovary syndrome	2.99e-05	0.00024	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	2.98e-05	0.00024	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GNAS—polycystic ovary syndrome	2.98e-05	0.000239	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—MTHFR—polycystic ovary syndrome	2.94e-05	0.000236	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—NCOR1—polycystic ovary syndrome	2.83e-05	0.000228	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	2.73e-05	0.000219	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CYP1A1—polycystic ovary syndrome	2.69e-05	0.000216	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IRS2—polycystic ovary syndrome	2.68e-05	0.000215	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	2.67e-05	0.000214	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	2.66e-05	0.000214	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—TH—polycystic ovary syndrome	2.66e-05	0.000214	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—LEP—polycystic ovary syndrome	2.62e-05	0.000211	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	2.6e-05	0.000209	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—SLC2A4—polycystic ovary syndrome	2.59e-05	0.000208	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.57e-05	0.000207	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	2.54e-05	0.000204	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—MTHFR—polycystic ovary syndrome	2.51e-05	0.000201	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	2.5e-05	0.000201	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.44e-05	0.000196	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP19A1—polycystic ovary syndrome	2.43e-05	0.000195	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PPARG—polycystic ovary syndrome	2.38e-05	0.000191	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	2.37e-05	0.000191	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—SERPINE1—polycystic ovary syndrome	2.35e-05	0.000189	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—POMC—polycystic ovary syndrome	2.35e-05	0.000189	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IRS1—polycystic ovary syndrome	2.34e-05	0.000188	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—INS—polycystic ovary syndrome	2.33e-05	0.000188	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	2.32e-05	0.000186	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—LHB—polycystic ovary syndrome	2.31e-05	0.000186	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	2.26e-05	0.000182	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—POMC—polycystic ovary syndrome	2.25e-05	0.000181	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	2.24e-05	0.00018	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—INS—polycystic ovary syndrome	2.24e-05	0.00018	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	2.19e-05	0.000176	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—IL6—polycystic ovary syndrome	2.19e-05	0.000176	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GNAS—polycystic ovary syndrome	2.17e-05	0.000174	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IGF1—polycystic ovary syndrome	2.16e-05	0.000174	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—AKT2—polycystic ovary syndrome	2.16e-05	0.000174	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—NCOR1—polycystic ovary syndrome	2.07e-05	0.000166	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	2.07e-05	0.000166	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.06e-05	0.000165	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	2.02e-05	0.000162	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—POMC—polycystic ovary syndrome	2e-05	0.000161	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	2e-05	0.000161	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—INS—polycystic ovary syndrome	1.99e-05	0.00016	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP1A1—polycystic ovary syndrome	1.96e-05	0.000157	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	1.95e-05	0.000157	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	1.93e-05	0.000155	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	1.88e-05	0.000151	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	1.85e-05	0.000149	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.84e-05	0.000148	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	1.83e-05	0.000147	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—MTHFR—polycystic ovary syndrome	1.83e-05	0.000147	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.82e-05	0.000146	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	1.81e-05	0.000145	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	1.79e-05	0.000144	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	1.73e-05	0.000139	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	1.7e-05	0.000137	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	1.69e-05	0.000136	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	1.66e-05	0.000133	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL6—polycystic ovary syndrome	1.66e-05	0.000133	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PPARG—polycystic ovary syndrome	1.48e-05	0.000119	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—TH—polycystic ovary syndrome	1.47e-05	0.000118	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—POMC—polycystic ovary syndrome	1.46e-05	0.000117	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—INS—polycystic ovary syndrome	1.45e-05	0.000117	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—TH—polycystic ovary syndrome	1.44e-05	0.000115	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	1.43e-05	0.000115	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.41e-05	0.000114	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	1.4e-05	0.000112	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	1.35e-05	0.000108	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	1.31e-05	0.000106	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	1.2e-05	9.66e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	1.17e-05	9.43e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	1.14e-05	9.2e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	1.12e-05	8.98e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	1.09e-05	8.72e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	1.06e-05	8.51e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	1.01e-05	8.13e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	9.87e-06	7.94e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL6—polycystic ovary syndrome	9.78e-06	7.86e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	8.2e-06	6.59e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	8.09e-06	6.5e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—INS—polycystic ovary syndrome	8.05e-06	6.47e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	8.01e-06	6.44e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—POMC—polycystic ovary syndrome	7.9e-06	6.35e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—INS—polycystic ovary syndrome	7.85e-06	6.31e-05	CbGpPWpGaD
